Understanding the benefits of GLP-1 drugs beyond obesity
In a Perspective, Daniel Drucker highlights the growing body of evidence that hints at the potential of glucagon-like peptide-1 (GLP-1)-based medications in treating conditions other than diabetes and obesity, including…
Proteins and fats can drive insulin production for some, paving way for tailored nutrition
When it comes to managing blood sugar levels, most people think about counting carbs. But new research from the University of British Columbia shows that, for some, it may be…
Semaglutide Reduces Severity of Common Liver Disease in People with HIV #CROI2024
A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according…